litlas
Log inCreate account

Jacques P. Brown

Active 1976–2025

124
Papers
30,385
Citations
86
h-index
121
i10-index

Citations

Citations per year for Jacques P. Brown1978: 1 citations1981: 1 citations1985: 5 citations1986: 14 citations1987: 7 citations1988: 15 citations1989: 5 citations1990: 14 citations1991: 14 citations1992: 9 citations1993: 10 citations1994: 8 citations1995: 4 citations1996: 18 citations1997: 10 citations1998: 24 citations1999: 35 citations2000: 72 citations2001: 75 citations2002: 96 citations2003: 124 citations2004: 140 citations2005: 157 citations2006: 183 citations2007: 171 citations2008: 208 citations2009: 175 citations2010: 235 citations2011: 194 citations2012: 190 citations2013: 152 citations2014: 202 citations2015: 217 citations2016: 207 citations2017: 229 citations2018: 291 citations2019: 808 citations2020: 950 citations2021: 779 citations2022: 627 citations2023: 404 citations2024: 771 citations2025: 351 citations2026: 6 citations1979–1980: no citations, so these years are not shown1982–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,961 citing papers, 21.3% of this breakdownCanada: 824 citing papers, 9% of this breakdownUnited Kingdom: 802 citing papers, 8.7% of this breakdownChina: 544 citing papers, 5.9% of this breakdownAustralia: 451 citing papers, 4.9% of this breakdownItaly: 396 citing papers, 4.3% of this breakdownGermany: 348 citing papers, 3.8% of this breakdownFrance: 316 citing papers, 3.4% of this breakdownJapan: 314 citing papers, 3.4% of this breakdownSwitzerland: 307 citing papers, 3.3% of this breakdownBelgium: 276 citing papers, 3% of this breakdownNetherlands: 248 citing papers, 2.7% of this breakdown
0%21.3%Other 26.3%

Institutions

Fields

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Engineering1%
  • Immunology and Microbiology1%
  • Health Professions0.9%
  • Neuroscience0.6%
  • Other3.2%

Topics

  • Bone health and osteoporosis research16.9%
  • Bone health and treatments11.9%
  • Bone Metabolism and Diseases7.9%
  • Bone and Joint Diseases5.5%
  • Hip and Femur Fractures4%
  • Parathyroid Disorders and Treatments2.5%
  • Other51.3%

Coauthors

All papers

Open in search
  1. Romosozumab in Postmenopausal Women with Low Bone Mineral Density

    Authors: Michael R. McClung, Andreas Grauer, Steven Boonen, Michael A. Bolognese, Jacques P. Brown, Adolfo Díez‐Pérez, Bente Langdahl, Jean‐Yves Reginster, José Zanchetta, Scott M. Wasserman, Leonid Katz, Judy Maddox, Yuching Yang, Cesar Libanati, Henry G. Bone - New England Journal of Medicine 2014 cited by 1,235

  2. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    Authors: Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi, Jacques P. Brown, Roland Chapurlat, Steven R. Cummings, E. J. Czerwiński, Astrid Fahrleitner‐Pammer, David L. Kendler, Kurt Lippuner, Jean‐Yves Reginster, Christian Roux, Jorge Malouf, Michelle N. Bradley, Nadia Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W. Dempster, Socrates E. Papapoulos - The Lancet Diabetes & Endocrinology 2017 cited by 961

  3. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    Authors: Bente Langdahl, Cesar Libanati, Daria B. Crittenden, Michael A. Bolognese, Jacques P. Brown, Nadia Daizadeh, Eva Dokoupilová, Klaus Engelke, Joel S. Finkelstein, Harry K. Genant, Stefan Goemaere, Lars Hyldstrup, Esteban Jódar-Gimeno, Tony M. Keaveny, David L. Kendler, Péter Lakatos, Judy Maddox, Jorge Malouf, Fabio Massari, José Fernando Molina, María Rosa Ulla, Andreas Grauer - The Lancet 2017 cited by 467

  4. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

    Authors: Dora Liu, Alexandra Ahmet, Leanne M. Ward, Preetha Krishnamoorthy, Efrem D. Mandelcorn, Richard Leigh, Jacques P. Brown, Albert Cohen, Harold Kim - Allergy Asthma and Clinical Immunology 2013 cited by 1,250

  5. Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    Authors: Aliya Khan, Archie Morrison, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O’Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah Morgan, Barbara Obermayer‐Pietsch, Bente Langdahl, Rana Al Dabagh, Kelly Davison, David L. Kendler, George K.B. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad A. Sulimani, Deborah Saunders, Jacques P. Brown, Juliet Compston, on behalf of the International Task Force on Osteonecrosis of the Jaw - Journal of Bone and Mineral Research 2014 cited by 1,345

  6. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

    Authors: Steven R. Cummings, Serge Ferrari, Richard Eastell, Nigel Gilchrist, Jens‐Erik Beck Jensen, Michael R. McClung, Christian Roux, Ove Törring, Ivo Valter, Andrea T Wang, Jacques P. Brown - Journal of Bone and Mineral Research 2017 cited by 709

  7. Long-Term Treatment of Postmenopausal Osteoporosis

    Authors: Jacques P. Brown - Endocrinology and Metabolism 2021 cited by 200

  8. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

    Authors: J. A. Kanis, Anders Odén, Olof Johnell, Helena Johansson, Chris De Laet, Jacques P. Brown, P. Burckhardt, Cyrus Cooper, Claus Christiansen, Steven R. Cummings, John A. Eisman, Saeko Fujiwara, Claus‐Christian Glüer, David Goltzman, D. Hans, M. A. Krieg, AZ La Croix, Eugène McCloskey, Dan Mellström, L. Joseph Melton, Huibert A. P. Pols, J. Reeve, Kerrie M. Sanders, Anne‐Marie Schott, Alan J. Silman, David Torgerson, Tjeerd van Staa, Nelson B. Watts, Noriko Yoshimura - Osteoporosis International 2007 cited by 1,223

  9. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

    Authors: Eugène McCloskey, Anders Odén, Nicholas C. Harvey, William D. Leslie, Didier Hans, Helena Johansson, Reinhard Barkmann, Stéphanie Boutroy, Jacques P. Brown, Roland Chapurlat, Petra J. M. Elders, Yuki Fujita, Claus‐C. Glüer, David Goltzman, Masayuki Iki, Magnus K. Karlsson, Andreas Kindmark, Mark A. Kotowicz, Norio Kurumatani, Timothy Kwok, Oliver Lamy, Jason Leung, Kurt Lippuner, Östen Ljunggren, Mattias Lorentzon, Dan Mellström, Thomas Merlijn, Ling Oei, Claes Ohlsson, Julie A. Pasco, Fernando Rivadeneira, Björn E. Rosengren, Elisabeth Sornay‐Rendu, Paweł Szulc, Junko Tamaki, John А. Kanis - Journal of Bone and Mineral Research 2015 cited by 735

  10. Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study

    Authors: Michael R. McClung, Jacques P. Brown, Adolfo Díez‐Pérez, Heinrich Resch, John Caminis, Paul Meisner, Michael A. Bolognese, Stefan Goemaere, Henry G. Bone, José Zanchetta, Judy Maddox, Sarah Bray, Andreas Grauer - Journal of Bone and Mineral Research 2018 cited by 231

  11. Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

    Authors: Pascale Chavassieux, Roland Chapurlat, Nathalie Portero-Muzy, Jean‐Paul Roux, Pedro Aljama García, Jacques P. Brown, Cesar Libanati, Rogely Boyce, Andrea Wang, Andreas Grauer - Journal of Bone and Mineral Research 2019 cited by 167

  12. Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

    Authors: Paul D. Miller, Nicola Pannacciulli, Jacques P. Brown, E. J. Czerwiński, Bettina S. Nedergaard, Michael A. Bolognese, Jorge Malouf, Henry G. Bone, Jean‐Yves Reginster, Andrea Singer, C. Wang, Rachel B. Wagman, Steven R. Cummings - The Journal of Clinical Endocrinology & Metabolism 2016 cited by 234

  13. Skeletal responses to romosozumab after 12 months of denosumab

    Authors: Michael R. McClung, Michael A. Bolognese, Jacques P. Brown, Jean‐Yves Reginster, Bente Langdahl, Yifei Shi, Jen Timoshanko, Cesar Libanati, Arkadi Chines, Mary Oates - JBMR Plus 2021 cited by 73

  14. Current use of bone turnover markers in the management of osteoporosis

    Authors: Jacques P. Brown, Andrew Don-Wauchope, Pierre Douville, Caroline Albert, Samuel D Vasikaran - Clinical Biochemistry 2022 cited by 128

  15. Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

    Authors: Harry K. Genant, Klaus Engelke, Michael A. Bolognese, C. Mautalén, Jacques P. Brown, Chris Recknor, Stefan Goemaere, Thomas Fuerst, Yuching Yang, Andreas Grauer, Cesar Libanati - Journal of Bone and Mineral Research 2016 cited by 141

  16. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

    Authors: A. Papaioannou, Suzanne N. Morin, Angela M. Cheung, Stephanie A. Atkinson, Jacques P. Brown, Sidney Feldman, D.A. Hanley, Anthony B. Hodsman, S. A. Jamal, Stéphanie Kaiser, Brent Kvern, Kerry Siminoski, William D. Leslie - Canadian Medical Association Journal 2010 cited by 1,756

  17. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

    Authors: David L. Kendler, Christian Roux, Claude Laurent Benhamou, Jacques P. Brown, Michael Lillestol, Suresh Siddhanti, H Man, Javier San Martín, Henry G. Bone - Journal of Bone and Mineral Research 2009 cited by 451

  18. Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression

    Authors: Claudia Beaudoin, Lynne Moore, Mathieu Gagné, Louis Bessette, L.-G. Ste-Marie, Jacques P. Brown, Sonia Jean - Osteoporosis International 2019 cited by 106

  19. Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial

    Authors: Erik Fink Eriksen, Roland Chapurlat, Rogely Boyce, Yifei Shi, Jacques P. Brown, S. Horlait, Donald Betah, Cesar Libanati, Pascale Chavassieux - Journal of Bone and Mineral Research 2020 cited by 45

  20. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

    Authors: Jacques P. Brown, Klaus Engelke, Tony M. Keaveny, Arkadi Chines, Roland Chapurlat, A. Joseph Foldes, Xavier Nogués, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano A. F. Zerbini, Zhenxun Wang, Mary Oates, Christopher Recknor, Cesar Libanati - Journal of Bone and Mineral Research 2021 cited by 73

  21. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

    Authors: Jacques P. Brown, Richard L. Prince, Chad Deal, Robert R. Recker, Douglas P. Kiel, Luiz H de Gregorio, Peyman Hadji, Lorenz C. Hofbauer, José María Álvaro‐Gracia, Huei Wang, Matthew Austin, Rachel B. Wagman, Richard Newmark, Cesar Libanati, Javier San Martín, Henry G. Bone - Journal of Bone and Mineral Research 2008 cited by 604

  22. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

    Authors: Michael R. McClung, MA Bolognese, Jacques P. Brown, Jean‐Yves Reginster, Bente Langdahl, Judy Maddox, Yifei Shi, Maria Rojeski, Paul Meisner, Andreas Grauer - Osteoporosis International 2020 cited by 49

  23. Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario

    Authors: Jacques P. Brown, Jonathan D. Adachi, Emil H. Schemitsch, Jean‐Éric Tarride, Vivien Brown, Alan Bell, Maureen Reiner, Thiago Oliveira, Ponda Motsepe-Ditshego, Natasha Burke, Lubomira Slatkovska - BMC Musculoskeletal Disorders 2021 cited by 107

  24. Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

    Authors: Serge Ferrari, Cesar Libanati, Celia J. F. Lin, Jacques P. Brown, Felicia Cosman, E. J. Czerwiński, LH de Gregόrio, Jorge Malouf-Sierra, J-Y. Reginster, A. Wang, RB Wagman, E. Michael Lewiecki - Journal of Bone and Mineral Research 2019 cited by 107